Rutherford Health

Rutherford Health was a private oncology provider founded by Mike Moran and Karol Sikora in 2015, with investment from Neil Woodford and the Wales Life Sciences Investment Fund, to develop proton therapy facilities in the United Kingdom and elsewhere. Until 2019 it was known as Proton Partners International.[1]

It went into liquidation in June 2022.[2][3] According to major shareholder Schroders UK Public Private Trust, the company had pursued a "flawed expansion strategy ... from 2015 to 2019" leading to "a high and unsustainable cash burn".[4][5][6]

  1. ^ "Rutherford Health PLC - Overview". Companies House. Retrieved 11 June 2020.
  2. ^ Wise, Jacqui (6 June 2022). "Private cancer provider collapses despite drive to tackle NHS backlog". BMJ. pp. o1401. doi:10.1136/bmj.o1401.
  3. ^ "Staff "devastated" after Rutherford Health liquidation". Society of Radiographers. 6 June 2022.
  4. ^ "Rutherford Health preparation to wind-up". Association of Investment Companies. Schroder UK Public Private Trust. 6 June 2022.
  5. ^ Carding, Nick (6 June 2022). "Cancer provider collapses despite NHS catch-up drive". Health Service Journal. Retrieved 7 June 2022.
  6. ^ Kilgannon, Laurence (6 June 2022). "Rutherford Health makes preparations to wind-up". Insider Media.